S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
S&P 500   3,329.35 (+0.26%)
DOW   29,228.32 (+0.11%)
QQQ   224.75 (+0.66%)
AAPL   319.24 (+0.84%)
FB   222.33 (+0.40%)
MSFT   166.50 (+0.00%)
GOOGL   1,492.31 (+0.68%)
AMZN   1,894.19 (+0.12%)
CGC   24.31 (+0.66%)
NVDA   251.98 (+1.63%)
MU   59.70 (+1.24%)
GE   11.36 (-2.57%)
TSLA   587.92 (+7.44%)
AMD   51.77 (+1.41%)
T   39.07 (+1.40%)
ACB   2.04 (+1.49%)
F   9.20 (-0.11%)
NFLX   329.47 (-2.56%)
BAC   34.30 (+0.12%)
DIS   144.00 (+0.31%)
GILD   63.10 (+0.75%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NYSE:KEM - KEMET Stock Price, Forecast & News

$26.49
+0.01 (+0.04 %)
(As of 01/22/2020 01:10 PM ET)
Today's Range
$26.42
Now: $26.49
$26.54
50-Day Range
$26.40
MA: $26.71
$27.05
52-Week Range
$15.87
Now: $26.49
$27.61
Volume17,459 shs
Average Volume941,688 shs
Market Capitalization$1.54 billion
P/E Ratio9.85
Dividend Yield0.56%
Beta2.65
KEMET Corporation manufactures and sells passive electronic components under the KEMET brand worldwide. The company operates in three segments: Solid Capacitors, Film and Electrolytic; and Electro-Magnetic, Sensors, and Actuators. It offers tantalum, aluminum polymer, and ceramic capacitors; film, paper, and wet aluminum electrolytic capacitors; electromagnetic interference filters; and electro-magnetic compatible materials and devices, piezo materials and actuators, and various types of sensors. Read More…

Industry, Sector and Symbol

Industry Electronic components & accessories
Sub-IndustryElectronic Manufacturing Services
SectorComputer and Technology
CUSIP48836020
Phone954-766-2800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.38 billion
Cash Flow$4.34 per share
Book Value$11.06 per share

Profitability

Net Income$206.59 million

Miscellaneous

Employees14,350
Market Cap$1.54 billion
Next Earnings Date1/30/2020 (Estimated)
OptionableOptionable

Receive KEM News and Ratings via Email

Sign-up to receive the latest news and ratings for KEM and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

One of the best ways to double, if not triple your investment in 2020 will be found in tech stocks. Especially those involved with the 5G rollout, where we're still finding undervalued opportunities. In our latest special report, we detail these and other hot tech stocks that should be part of your portfolio right now.

KEMET (NYSE:KEM) Frequently Asked Questions

What is KEMET's stock symbol?

KEMET trades on the New York Stock Exchange (NYSE) under the ticker symbol "KEM."

How often does KEMET pay dividends? What is the dividend yield for KEMET?

KEMET declared a quarterly dividend on Thursday, August 1st. Stockholders of record on Thursday, August 15th will be paid a dividend of $0.05 per share on Monday, August 26th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date of this dividend is Wednesday, August 14th. View KEMET's Dividend History.

How were KEMET's earnings last quarter?

KEMET Co. (NYSE:KEM) announced its earnings results on Tuesday, November, 12th. The electronics maker reported $0.66 earnings per share for the quarter, hitting the Zacks' consensus estimate of $0.66. The electronics maker earned $327.40 million during the quarter, compared to analyst estimates of $324.90 million. KEMET had a return on equity of 32.53% and a net margin of 11.56%. The company's revenue for the quarter was down 6.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.87 earnings per share. View KEMET's Earnings History.

When is KEMET's next earnings date?

KEMET is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for KEMET.

What guidance has KEMET issued on next quarter's earnings?

KEMET issued an update on its third quarter 2020 IntraDay earnings guidance on Monday, November, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $$285-300 million, compared to the consensus revenue estimate of $$333.9 million.

What price target have analysts set for KEM?

2 brokers have issued 12 month target prices for KEMET's stock. Their forecasts range from $26.00 to $27.20. On average, they expect KEMET's share price to reach $26.60 in the next year. This suggests a possible upside of 0.4% from the stock's current price. View Analyst Price Targets for KEMET.

What is the consensus analysts' recommendation for KEMET?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for KEMET in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for KEMET.

Has KEMET been receiving favorable news coverage?

Headlines about KEM stock have been trending negative on Wednesday, InfoTrie Sentiment reports. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. KEMET earned a media sentiment score of -2.3 on InfoTrie's scale. They also gave news stories about the electronics maker a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for KEMET.

Are investors shorting KEMET?

KEMET saw a drop in short interest in December. As of December 31st, there was short interest totalling 6,150,000 shares, a drop of 32.8% from the December 15th total of 9,150,000 shares. Based on an average daily volume of 1,880,000 shares, the short-interest ratio is presently 3.3 days. Currently, 11.0% of the company's stock are sold short. View KEMET's Current Options Chain.

Who are some of KEMET's key competitors?

What other stocks do shareholders of KEMET own?

Who are KEMET's key executives?

KEMET's management team includes the folowing people:
  • Mr. William M. Lowe Jr., CEO & Director (Age 66)
  • Mr. Ronald James Assaf, Sr. VP, Gen. Counsel & Sec. (Age 59)
  • Mr. Charles C. Meeks Jr., Exec. VP of Solid Capacitors (Age 58)
  • Mr. Shigenori Oyama, Exec. VP of Magnetics, Sensors & Actuators (Age 62)
  • Mr. Gregory C. Thompson, Exec. VP & CFO (Age 63)

Who are KEMET's major shareholders?

KEMET's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Calamos Advisors LLC (0.27%), State of Alaska Department of Revenue (0.08%), Louisiana State Employees Retirement System (0.03%), 6 Meridian (0.02%), Janney Montgomery Scott LLC (0.02%) and Steward Partners Investment Advisory LLC (0.00%). Company insiders that own KEMET stock include Charles C Meeks Jr, Claudio Lollini, Gregory C Thompson, Gurminder S Bedi, Per Olof Loof, Robert G Paul, Ronald James Assaf, Shignori Oyama and William M Lowe Jr. View Institutional Ownership Trends for KEMET.

Which institutional investors are selling KEMET stock?

KEM stock was sold by a variety of institutional investors in the last quarter, including Steward Partners Investment Advisory LLC, Louisiana State Employees Retirement System, Janney Montgomery Scott LLC and State of Alaska Department of Revenue. Company insiders that have sold KEMET company stock in the last year include Charles C Meeks Jr, Robert G Paul, Ronald James Assaf and Shignori Oyama. View Insider Buying and Selling for KEMET.

Which institutional investors are buying KEMET stock?

KEM stock was acquired by a variety of institutional investors in the last quarter, including Calamos Advisors LLC and 6 Meridian. View Insider Buying and Selling for KEMET.

How do I buy shares of KEMET?

Shares of KEM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is KEMET's stock price today?

One share of KEM stock can currently be purchased for approximately $26.49.

How big of a company is KEMET?

KEMET has a market capitalization of $1.54 billion and generates $1.38 billion in revenue each year. The electronics maker earns $206.59 million in net income (profit) each year or $3.37 on an earnings per share basis. KEMET employs 14,350 workers across the globe.View Additional Information About KEMET.

What is KEMET's official website?

The official website for KEMET is http://www.kemet.com/.

How can I contact KEMET?

KEMET's mailing address is KEMET TOWER ONE EAST BROWARD BLVD., FORT LAUDERDALE FL, 33301. The electronics maker can be reached via phone at 954-766-2800 or via email at [email protected]


MarketBeat Community Rating for KEMET (NYSE KEM)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  331 (Vote Outperform)
Underperform Votes:  309 (Vote Underperform)
Total Votes:  640
MarketBeat's community ratings are surveys of what our community members think about KEMET and other stocks. Vote "Outperform" if you believe KEM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KEM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Featured Article: Bond

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel